Hi all,
In the couple of years that I've had MS, it seems that although there is a steady stream of information generated about MS, some of the more notable results from research are presented at the major neurology conferences. I was wondering if there is a comprehensive list of the major conferences, so one might have an idea of when to expect these sorts of things. For example, I googled AAN and their yearly meeting is at the end of April and beginning of May.
best to all,
ThinkingOutLoud
Neurology Conferences
- thinkingoutloud86
- Family Elder
- Posts: 122
- Joined: Wed May 31, 2006 2:00 pm
The major ones are ECTRIMS (mid-October), ACTRIMS (early June) and the UK MS Society Research Conference (mid-June). Links as follows:
http://www.akm.ch/ectrims2007/
Ectrims receives a huge number of research papers / results of trials. Topics being discussed this year are:
- Pathogenesis of MS: what have we learned during the last decades?
- CNS repair and neuroprotection
- Immunosuppression revisited: benefits and risks
- Early MS: to treat or not to treat?
- MRI: reliable surrogate marker?
http://www.actrims.org/
The following presentations being given are:
12th Annual Meeting of ACTRIMS
Emerging Therapies in Multiple Sclerosis
Therapeutic Monoclonal Antibodies: An Overview
Professor Herman Waldmann
Natalizumab Therapy in Multiple Sclerosis
Olaf Stuve, MD, PhD
Use of Daclizumab in Multiple Sclerosis
Bibi Bielekova, MD
Studies on Rituximab in the Treatment of Multiple Sclerosis
Emmanuelle Waubant, MD, PhD
Beyond the Monoclonals: Promising Oral Agents and Neuroprotective Strategies Peter Calabresi, MD
Designing Rational Clinical Trials for New and Emerging Therapies
Fred Lublin, MD
http://www.mssociety.org.uk/document.rm?id=2362
It's encouraging to see that the presentations are moving beyond the current injectibles and that more attention is being paid to neuro-protection. Mr Z, a big fan of Tysabri, will be pleased that monoclonal antibodies feature strongly.
Ian
http://www.akm.ch/ectrims2007/
Ectrims receives a huge number of research papers / results of trials. Topics being discussed this year are:
- Pathogenesis of MS: what have we learned during the last decades?
- CNS repair and neuroprotection
- Immunosuppression revisited: benefits and risks
- Early MS: to treat or not to treat?
- MRI: reliable surrogate marker?
http://www.actrims.org/
The following presentations being given are:
12th Annual Meeting of ACTRIMS
Emerging Therapies in Multiple Sclerosis
Therapeutic Monoclonal Antibodies: An Overview
Professor Herman Waldmann
Natalizumab Therapy in Multiple Sclerosis
Olaf Stuve, MD, PhD
Use of Daclizumab in Multiple Sclerosis
Bibi Bielekova, MD
Studies on Rituximab in the Treatment of Multiple Sclerosis
Emmanuelle Waubant, MD, PhD
Beyond the Monoclonals: Promising Oral Agents and Neuroprotective Strategies Peter Calabresi, MD
Designing Rational Clinical Trials for New and Emerging Therapies
Fred Lublin, MD
http://www.mssociety.org.uk/document.rm?id=2362
It's encouraging to see that the presentations are moving beyond the current injectibles and that more attention is being paid to neuro-protection. Mr Z, a big fan of Tysabri, will be pleased that monoclonal antibodies feature strongly.
Ian
- thinkingoutloud86
- Family Elder
- Posts: 122
- Joined: Wed May 31, 2006 2:00 pm
- ClancyPavillion
- Getting to Know You...
- Posts: 17
- Joined: Thu Mar 08, 2007 3:00 pm
- Location: New England
I'll be at the conference in Holyoke, MA on Wednesday April 4. It's put on by Biogen, so it's of course going to be heavily promoting Avonex etc. Anyway... I'm stoked to just get out and meet folks anyway! Anyone else going??
"Some women aren't meant to be tamed... we are meant to run free until we find someone just as wild to run with"